Biotech Stalls at Resistance

December 24, 2024 By in $SPSIBI, Biotech, LABD, LABD-24-21, SPBIO, XBI

Losing Upside Energy

Today was a shortened trading day, so there may need to be more (resistance) confirmation in the coming sessions.

With that, we can see the biotech index SPBIO, has stalled at resistance.

The chart shows there were five-months of support, broken to the downside, now becoming resistance

Biotech SPBIO, Daily


As stated in the last update, the market itself is not giving indications the current short position, LABD-24-21, requires and exit (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Sector (pure) Detail

December 23, 2024 By in $SPSIBI, Biotech, LABD, LABD-24-21, SPBIO, XBI 1 Comment

More Fibonacci Correlations

The sector index SPBIO, is shown in the chart below.

Although there’s no volume data, there isn’t any ‘transaction slippage’, or ‘management fee’ skew errors either.

As of this update (1:03, p.m., EST) the SPBIO (XBI) is trying its best to post a new daily high … attempting to grind its way higher.

For now, it’s not happening.

Biotech SPBIO, Daily

The channel shown, discussed in this update.

Not presented at that time, the apparent Fibonacci count from the left-most channel contact to the latest daily high contact (Friday).

From a trading perspective, from a position of being short this market (LABD-24-21), there’s no specific indication to exit the position (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Carvana Cracks

December 22, 2024 By in CVNA, KMX, The Epoch Times, Wyckoff Tags: , , , ,

Same As It Ever Was?

It’s a market smorgasbord of opportunities but for this site, it’s not to the upside (not advice, not a recommendation).

Let’s get started with this:

‘The economy’s doing great, same as it ever was’

Just to remind us how great it is, is this, link here.

Moving on to the poster child of the day, Carvana.

As expected, the CarMax (KMX) earnings release, affected not only CarMax, but Carvana’s price action as well.

The last update on Carvana said to be on the lookout for a reversal based on the lack of volatility alone.

Well, that’s what happened, and volatility has increased.

Carvana CVNA, Daily

The question now: CVNA price action has declined and penetrated established support, putting it in Wyckoff ‘spring’ position.

Will there be one (potential) last ‘blip’ higher?

Of course, CVNA could head down from here.

Price action over the next few days, will let us know the most likely outcome.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

‘Massive’ Short Squeeze, Really?

December 21, 2024 By in $SPSIBI, Biotech, LABD, LABD-24-21, SPBIO, XBI, ZeroHedge 1 Comment

Hey, Rocky! … Watch Me Pull Hyperbole Out of my Hat

The financial press says, on Friday, the shorts got slaughtered.

Is that true, or just more hyperbole?

To find out, we’ll take a look at the active short in biotech XBI, and see if there was a ‘slaughter’, or something more constructive.

Biotech XBI, Daily

The last post inferred, ‘there’s no end in sight’ (not advice, not a recommendation).

Is that still true?

A present, we have a channel (with center-line) whose sections are a Fibonacci multiple.

If the channel is still in effect and the next session does not decisively break to the upside, then we can see price action is testing and validation that right side.

The good part or scary part depending on one’s perspective, XBI is validating the ‘supply’ side of the channel (where selling occurs).

Way down lower, is the ‘demand’ side … way down.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Down … No End In Sight

December 20, 2024 By in $SPSIBI, Biotech, LABD, LABD-24-21, SPBIO, Wyckoff, XBI, XBI-24-01 Tags: , , , , 1 Comment

Parallel Channels

Moves that take years to develop, once started, can go on much longer than anyone would expect.

Depending on your viewpoint, biotech XBI, has been congesting sideways (in a range) from one-to-three years.

Either way, the current breakdown suggests the potential for a sustained down trend (not advice, not a recommendation).

Biotech XBI, Daily

Remember, Wyckoff said the market itself, will tell us what levels and trendlines are significant.

If the current (right-side) channel is valid, the market itself shows us a similar channel in the past.

Two things to note.

First: Record Volume

As far as known (source, TC2000), November 15th’s volume of 30.3 million, was the largest ever recorded for the XBI:

That’s ‘thirty-point-three’ (thirty-three), you can’t make this stuff up. 🙂

Second: Short Position

There were two attempts to short this market.

Trade: XBI-24-01

Actual, sell-short, closed with -0.40%, loss

Trade: LABD-24-21

Leveraged inverse fund LABD, currently open with +27.31%, profit (as of 9:02 a.m., EST).

Volatility & Leveraged Inverse

The objective is to trade short using LABD, for as long as practical (not advice, not a recommendation).

If the XBI begins to get volatile with wide swings and chop either up or down, slippage-decay on inverse funds becomes prohibitive.

LABD-24-21 may be exited at any time, without notice.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The CarMax Question

December 19, 2024 By in Biotech, Car Questions Answered, Interest Rates, KMX, Real Estate, Russell 2000 Tags: , , , , 1 Comment

Something’s Not Right

If the future’s so bright for CarMax, with them beating estimates for earnings and revenue, link here, why did it sell-off immediately after the open?

Trading, (as of 12:20 p.m., EST) currently at 85.15, below well-established resistance.

As we’ve seen by now, relying on financial numbers, any numbers, is akin to a ‘snipe hunt’ (remember those?).

The prior update on KMX, said this:

“Let’s see if KMX, uses earnings as an ‘excuse’ for launch to 38.2% retrace level (or higher).”

Adding to that, we had ‘boots on the ground’, like this.

Now, based on price action, we have the potential ‘false breakout’, exactly as was forecast, link here (not advice, not a recommendation).

CarMax KMX, Weekly

The breakout appears to be failing or has failed already (not advice, not a recommendation).

With other markets in full-blown melt-down like biotech, real estate, interest rates and the Russell, it’s possible CarMax adds one more economic reality to the mix no matter what the ‘numbers’ say (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Silver/Gold Miners (crash) Channel

December 18, 2024 By in GDX, GDXJ, Gold & Silver, Gold Miners, SILJ Tags: , , , ,

Unfolding Quickly

The past two months have seen the miners, GDX, GDXJ, SILJ, reverse down, hit a low, then upside test and now, reverse down again.

For years, the big picture analysis of this sector has been consistently bearish.

Sure, there we upside opportunities but the (more) dynamic moves were to the downside.

All of which, brings us to now.

Senior Miners GDX, Weekly

A sideways market is a bear market; that’s what we’ve had for over four years (not advice, not a recommendation).

A ‘terminating wedge’ taking a year to form has broken to the downside.

Then, an upward recovery (test), that reversed last week, continuing to the downside this week.

Looking to the left on the chart, we see the ‘repeating’ channel.

This notation shows a down-channel of this type has happened before. The market itself, has set its own precedent.

At this juncture, this week’s right -side channel line is declining at approximately -95%, annualized.

Decide for yourself if that type of trend constitutes a ‘crash’ (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

All Jobs … ‘Fake’

December 17, 2024 By in $SPSIBI, Biotech, LABD, LABD-24-21, SPBIO, Wyckoff, XBI Tags: ,

What’s The ‘Real’ Message

Like a scene out of Animal House, we have Tomfoolery going on with ‘official’ data, out of ‘reliable’ sources.

Turns out, at least in this case, the data’s fake.

Earlier in the year, we had 800,000 jobs. That was fake as well.

The message that most if not all have missed, is the market’s response to the fakery:

The markets have responded to revelations of fake data by doing … nothing. No wild swings, no major gaps lower or higher, nothing.

That’s the real message.

This site’s focused on what the market’s actually telling us, not what the (fake) financial press tries to tell us.

All of which, brings us to biotech.

Biotech Sector SPSIBI (SPBIO), Daily

We’re using ‘pure’ index (in this example) as the XBI, has minor differences, obscuring the Fibonacci sequence.

Price action’s consistent with establishing and confirming a right-side trend line (not advice, not a recommendation).

With that said, there has not been a new daily low … yet.

So, there’s still the possibility of breaking the downtrend (line) and morphing into something different.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

A Tale of Two Markets

December 16, 2024 By in $SPSIBI, Artificial Intelligence, Biotech, LABD, LABD-24-21, Semiconductors, SOXX, SPBIO, XBI Tags: , , , ,

SOXX Powering Higher, XBI Pivoting Lower

To borrow from the Dickens classic:

It was the bullish of times, it was the bearish of times.

Bulls have regained control of the semiconductors (SOXX) for now and negated the ‘false breakout’ analysis link here.

Meanwhile, bears have moved into biotech XBI; currently testing underside resistance and axis line.

Since the active trade (LABD-24-21) is in biotech, we’ll review that market (not advice, not a recommendation).

Biotech XBI, Weekly

The weekly shows us the ‘Axis Line’ has been part of XBI price action for at least three years.

Moving on to the daily, more detail.

Biotech XBI, Daily

There was (decisive) downside penetration, November 15th. Then, an attempted recovery that so far, has failed.

The notation ‘Short?’, was the date of this post.

As the semiconductors battle over who’s in control, for biotech, the bears seem to have established a foothold (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Seven-Year ‘Wedge’

December 15, 2024 By in $SPSIBI, 2007 - 2008, Biotech, Bonds, DHI, Interest Rates, LABD, LABD-24-16, SPBIO, TLT, XBI Tags: , , , ,

Massive Top Formation

D.R. Horton, (DHI) is the largest cap in the Residential Construction Sector (www.tc2000.com).

During the last blow-up (2005 – 2008), DHI, declined top-to-bottom over -91%.

Will it be different this time?

One thing that’s likely, the next implosion could be hit with widespread market and broker outages (not advice, not a recommendation).

The last (notable) time was here.

As far as known, feel free to comment to the contrary, this site’s the only one that incorporates outage potential (and reality) into its trading plan.

Case in point is this link.

The firm’s trade records show, on that Monday, the account was short: LABD-24-16.

The broker outage and panic helped the position. The trade was closed on August 8th, with a profit of 11.15%.

Enough said, let’s move on.

D.R. Horton DHI, Monthly

There it is, seven-years in the making.

We’re at the lower wedge boundary now.

Recently, bonds (TLT) had a minor move higher (rates lower), lasting two-weeks.

However, last week, TLT reversed down and eclipsed the previous two-weeks of gains.

Rates are now moving higher … again.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279